Fulcrum Therapeutics Inc.
FULC | NASDAQ
$3.80
+$0.04 (+1.06%)
At close: Sep 21, 2026, 4:00 PM ET
$3.79
-$0.01 (-0.26%)
Pre-market:
Sep 22, 2026, 7:10 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | 80M | 80M | 80.87M | 81.63M | 2.51M | 2.81M | 2.62M | 3.04M | 4.05M | 6.34M | 10.72M | 14.47M | 16.97M | 19.16M | 18.33M | 15.24M | 12.86M |
Cost of Revenue | 14.33M | 14.63M | 27.7M | 28.37M | 28.71M | 45.67M | 32.75M | 32.89M | 36.49M | 37.07M | 53.31M | 71.37M | 68.5M | 75.67M | 76.78M | 77.13M | 78.84M | 71.2M | 69.7M | 66.93M | 65.5M | 60.89M |
Gross Profit | -14.33M | -14.63M | -27.7M | -28.37M | -28.71M | 34.33M | 47.25M | 47.98M | 45.14M | -34.56M | -50.51M | -68.75M | -65.45M | -71.62M | -70.44M | -66.41M | -64.37M | -54.23M | -50.54M | -48.6M | -50.25M | -48.03M |
Operating Income | -96.05M | -86.55M | -84.77M | -81.51M | -84.77M | -12.47M | -21.9M | -30.46M | -32.77M | -112.56M | -110.66M | -110.65M | -107.56M | -114.5M | -112.56M | -108.15M | -104.56M | -90.01M | -81.05M | -75.28M | -73.62M | -69.86M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.51M | 3.51M | 3.51M | 3.51M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -85M | -76.12M | -74.88M | -71.11M | -73.22M | -510K | -9.73M | -17.91M | -20.23M | -99.43M | -97.34M | -98.71M | -98.44M | -108.72M | -109.87M | -107.22M | -104.2M | -89.78M | -80.85M | -75.08M | -73.33M | -69.37M |
Net Income | -85M | -76.12M | -74.88M | -71.11M | -73.22M | -510K | -9.73M | -17.91M | -20.23M | -99.43M | -97.34M | -98.71M | -98.44M | -108.72M | -109.87M | -107.22M | -104.2M | -89.78M | -80.85M | -75.08M | -73.33M | -69.37M |
Selling & General & Admin | 30.4M | 29.77M | 28.67M | 29.11M | 29.97M | 33.39M | 36.45M | 38.09M | 39.63M | 39.7M | 41.16M | 41.93M | 41.68M | 42.46M | 41.69M | 41.27M | 40.19M | 35.78M | 30.52M | 26.68M | 23.36M | 21.83M |
Research & Development | 56.24M | 56.78M | 56.1M | 52.03M | 52.37M | 56.65M | 62.54M | 70.19M | 73.79M | 74.38M | 71.8M | 71.37M | 68.5M | 75.67M | 76.78M | 77.13M | 78.84M | 71.2M | 69.7M | 66.93M | 65.5M | 60.89M |
Other Expenses | -4.93M | -14.63M | -27.7M | -28M | -26.28M | -43.24M | -29.84M | -29.84M | -35.5M | -36.09M | -52.8M | -71.41M | -68.07M | -75.24M | -76.36M | -76.66M | -78.84M | -71.2M | -69.7M | -66.93M | -65.5M | -60.89M |
Operating Expenses | 81.71M | 71.92M | 57.07M | 53.14M | 56.06M | 46.79M | 69.15M | 78.44M | 77.92M | 77.99M | 60.16M | 41.9M | 42.11M | 42.88M | 42.12M | 41.73M | 40.19M | 35.78M | 30.52M | 26.68M | 23.36M | 21.83M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 260K | 260K | 568K | 568K | 593K | 864K | 556K | 48K | 403K | 748K | 1.41M | 1.34M | 1.27M | 1.18M | 967K | 913K | 568K | 233K | n/a | 623K | 399K | 403K |
Cost & Expenses | 66.74M | 86.55M | 84.77M | 81.51M | 84.77M | 92.47M | 101.9M | 111.33M | 114.4M | 115.07M | 113.47M | 113.26M | 110.6M | 118.55M | 118.9M | 118.86M | 119.03M | 106.98M | 100.22M | 93.61M | 88.86M | 82.72M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 76.26M | 76.22M | 63.36M | 62.6M | 62.54M | 62.48M | 53.95M | 62.41M | 62.21M | 61.98M | 61.87M | 61.82M | 61.79M | 59.72M | 52.08M | 46.21M | 40.89M | 40.64M | 40.58M | 36.61M | 32.64M | 31.51M |
Shares Outstanding (Diluted) | 76.26M | 76.22M | 63.36M | 62.6M | 62.54M | 62.48M | 53.95M | 62.41M | 63.59M | 61.98M | 61.87M | 61.82M | 61.79M | 59.72M | 52.08M | 46.21M | 40.89M | 40.64M | 40.58M | 36.61M | 32.64M | 31.51M |
EPS (Basic) | -1.21 | -1.15 | -1.18 | -1.18 | -1.22 | -0.05 | -0.20 | -0.29 | -0.33 | -1.60 | -1.53 | -1.58 | -1.71 | -2.16 | -2.44 | -2.57 | -2.62 | -2.39 | -2.29 | -2.35 | -2.48 | -2.54 |
EPS (Diluted) | -1.21 | -1.15 | -1.18 | -1.18 | -1.22 | -0.07 | -0.22 | -0.31 | -0.35 | -1.60 | -1.53 | -1.58 | -1.71 | -2.16 | -2.44 | -2.57 | -2.62 | -2.39 | -2.29 | -2.35 | -2.48 | -2.54 |
EBITDA | -87.1M | -74.74M | -73.49M | -69.7M | -73.15M | -410K | -9.5M | -17.55M | -18.34M | -97.34M | -95.16M | -98.34M | -98.13M | -108.31M | -109.49M | -104.93M | -101.75M | -87.33M | -78.38M | -72.57M | -71.02M | -67.42M |
EBIT | -58.82M | -76.12M | -74.88M | -71.11M | -74.58M | -1.88M | -11.09M | -19.28M | -20.23M | -99.43M | -97.34M | -100.59M | -100.46M | -110.75M | -111.9M | -107.37M | -104.2M | -89.78M | -80.89M | -75.19M | -73.58M | -69.86M |
Depreciation & Amortization | 1.03M | 1.38M | 1.39M | 1.41M | 1.44M | 1.47M | 1.59M | 1.73M | 1.89M | 2.09M | 2.17M | 2.26M | 2.34M | 2.44M | 2.41M | 2.44M | 2.45M | 2.45M | 2.52M | 2.63M | 2.56M | 2.44M |
Add to Watchlist
Select watchlists to add or remove FULC